Lidocaine Patch 5%, packaged in 30-count cartons, Rx only, Manufactured by: Actavis Laboratories UT, Inc., Salt Lake City, UT 84108, USA, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054 USA, NDC 0591-3525-30
Published August 19, 2020 · Recall initiated: July 14, 2020
Summary
FDA records drug Class II recall D-1492-2020, published August 19, 2020 and initiated July 14, 2020. Recalling firm: Teva Pharmaceuticals USA; Status: Terminated; Reported quantity: 28,596 cartons; Lot: Carton Lot # 1383513B, Patch Lot # 1383513, Exp date 03/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Incorrect or Missing Lot and/or Exp date on the individual transdermal pouches but not in the carton.
What to do
Voluntary: Firm initiated · Letter
Get an email if LIDOCAINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LIDOCAINE
- Manufacturer
- Teva Pharmaceuticals USA
- Distributor
- Nationwide United States
- Lot
- Carton Lot # 1383513B, Patch Lot # 1383513, Exp date 03/2022
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALidocaine Ointment USP, 5%, Speermint Flavor, 50 g Jar, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton,September 23, 2026
- FDALidocaine HCl Injection, USP, 2%, 100 mg per 5 mL (20 mg per mL), 25 Single Dose Vials, 5 mL per vial, RxJuly 29, 2026
- FDALidocaine HCI 2% and Epinephrine 1:100,000 (Lidocaine HCI and Epinephrine Injection USP), packaged in a cartonDecember 24, 2025
- FDALidocaine Patch 5%, 1 patch (63629-8755-20) packaged in 30-count patches per carton (63629-8755-1), Rx only,May 10, 2023
- FDALeucovorin Calcium Tablets USP, 10 mg, Rx only, 24 Tablets per bottle, Distr. by: West-Ward PharmaceuticalsAugust 19, 2020
- FDANystatin Oral Suspension, USP 100,000 units per mL, Cherry/Peppermint Flavor, 16 fl. oz. (473 mL), Rx only,August 19, 2020
Questions about this recall
Was Lidocaine Patch 5%, packaged in 30-count cartons, Rx only, Manufactured by: Actavis Laboratories UT, Inc., Salt Lake City, UT 84108, USA, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054 USA, NDC 0591-3525-30 recalled?
Yes. FDA published recall D-1492-2020 on August 19, 2020. Reported hazard: Labeling: Incorrect or Missing Lot and/or Exp date on the individual transdermal pouches but not in the carton.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LIDOCAINE.